Severine Francine Jaspart

Title: Severine Francine Jaspart: Innovator in Pharmaceutical Dosage Units

Introduction

Severine Francine Jaspart is a notable inventor in the field of pharmaceuticals, particularly known for her work on orodispersible dosage units. Based in Belgium, she has contributed to the development of innovative pharmaceutical formulations that enhance drug delivery methods.

Latest Patents

Jaspart's latest patents include the invention of an orodispersible tablet containing estetrol. This invention provides a solid pharmaceutical dosage unit weighing between 30 and 1,000 mg, which contains at least 100 µg of an estetrol component. The manufacturing process involves mixing an aqueous liquid with carrier particles, followed by water removal to produce loaded particles. This solid dosage unit is designed for easy manufacturing and is suitable for sublingual, buccal, or sublabial administration. Another patent focuses on an orodispersible dosage unit containing an estetrol component, consisting of 0.1-25 wt.% of estetrol particles and 75-99.9 wt.% of other pharmaceutically acceptable ingredients. This formulation also emphasizes ease of manufacturing and administration.

Career Highlights

Severine Francine Jaspart is currently associated with Estetra Srl, where she continues to innovate in the pharmaceutical sector. Her work has significantly impacted the development of effective drug delivery systems.

Collaborations

Throughout her career, Jaspart has collaborated with notable professionals in her field, including Johannes Jan Platteeuw and Denny Johan Van Den Heuvel. These collaborations have contributed to her success and the advancement of her inventions.

Conclusion

Severine Francine Jaspart is a pioneering inventor whose contributions to orodispersible dosage units have the potential to transform pharmaceutical practices. Her innovative approaches to drug formulation highlight her commitment to improving patient care through effective medication delivery methods.